Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-31,668
Closed -$220K 105
2019
Q1
$220K Buy
+31,668
New +$270K 0.11% 47
2018
Q1
Sell
-15,918
Closed -$1.96M 174
2017
Q4
$1.96M Buy
15,918
+7,890
+98% +$965K 0.18% 54
2017
Q3
$954K Sell
8,028
-10,045
-56% -$1.13M 0.06% 76
2017
Q2
$1.95M Sell
18,073
-184
-1% -$18.8K 0.13% 69
2017
Q1
$1.9M Buy
18,257
+2,509
+16% +$253K 0.1% 96
2016
Q4
$1.58M Buy
15,748
+14,951
+1,876% +$2.07M 0.09% 121
2016
Q3
$151K Sell
797
-1,714
-68% -$268K 0.01% 279
2016
Q2
$258K Hold
2,511
0.01% 236
2016
Q1
$345K Buy
2,511
+550
+28% +$87.1K 0.02% 236
2015
Q4
$412K Buy
1,961
+1,503
+328% +$336K 0.02% 248
2015
Q3
$110K Hold
458
﹤0.01% 364
2015
Q2
$178K Hold
458
0.01% 301
2015
Q1
$275K Sell
458
-381
-45% -$220K 0.01% 257
2014
Q4
$554 Buy
+839
New +$554K 0.02% 183

Other funds holding OCGN

Sabby Management's OCGN Position: Q2 2019 in Review

Sabby Management sold out of Ocugen (OCGN) in Q2 2019, closing a stake of 31,668 shares — an estimated $220K sold.

Sabby Management first reported a position in OCGN in Q4 2014 and held it in 14 quarters. The position peaked at $1.96M in Q4 2017. 24 funds tracked by Wall St. Rank hold OCGN as of Q2 2019.

  • Sabby Management reported no remaining Ocugen position as of Q2 2019 after selling out during the quarter.
  • Sabby Management sold 31,668 Ocugen shares in Q2 2019, an estimated $220K.
  • Sabby Management first reported a position in Ocugen in Q4 2014 and held it in 14 quarters.
  • Sabby Management's Ocugen position peaked at $1.96M in Q4 2017.
  • 24 funds tracked by Wall St. Rank held Ocugen as of Q2 2019.

Based on Sabby Management's 13F filing for Q2 2019, filed 14 Aug 2019.